Skip to main content

Day: October 1, 2020

Adicet Bio to Present at the Jefferies Cell Therapy Summit

MENLO PARK, Calif. and BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer of Adicet Bio, and Stewart Abbot, Ph.D., Chief Scientific and Operating Officer of Adicet Bio, will participate in a fireside chat at the Jefferies Cell Therapy Summit on Monday, October 5, 2020 at 2:30 PM ET.A live audio webcast of the fireside chat can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.About Adicet Bio, Inc.Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell...

Continue reading

Bryn Mawr Trust Bolsters Commercial Lending Group, Adds Rachel Lindeman as Senior Vice President

BRYN MAWR, Pa., Oct. 01, 2020 (GLOBE NEWSWIRE) — Bryn Mawr Trust (BMT), wholly owned by Bryn Mawr Bank Corporation (NASDAQ: BMTC), announced today that Rachel Lindeman has joined the company as Senior Vice President and Commercial Real Estate Relationship and Construction Loan Manager. Rachel reports directly to Drew Smith, Commercial Real Estate (CRE) Banking Division leader. She manages high-profile CRE relationships and works with large developers throughout the state of Delaware to support initiatives to expand the bank’s presence in the state.She originates commercial real estate loans of varying exposures and product types, such as apartments, retail, office, and subdivision development. “Rachel is a superb manager of real estate investor/developer relationships, providing for the capital needs of CRE customers,” said Richard...

Continue reading

Delcath Strengthens Executive Team with Appointment of Gerard Michel as Chief Executive Officer

Gerard Michel Brings the Experience Needed to Lead Delcath as it Transitions from a Development to Commercial Stage CompanyJohn Purpura Appointed Chief Operating Officer with Operational, Manufacturing and Regulatory ResponsibilitiesNEW YORK, Oct. 01, 2020 (GLOBE NEWSWIRE) — Delcath Systems, Inc. (NASDAQ: DCTH) today announced that the Board of Directors appointed Gerard Michel as Chief Executive Officer, effective October 1, 2020. Mr. Michel will also serve as a member of the Delcath Systems Board of Directors. In his most recent role, Mr. Michel was the Chief Financial Officer and Vice President of Corporate Development at Vericel Corporation. Mr. Michel was a key member of the executive team that successfully restructured Vericel enabling it to become a commercial leader in the fields of advanced Cell Therapy and specialty Biologics.In...

Continue reading

Bold Announces Closing of a Private Placement of Approximately C$1,700,000 of Convertible Debentures of Dymedso, a Corporation Involved in Lung Disease Treatment and Treating COVID-19 Pulmonary Issues

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. WIRE NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTRÉAL, Oct. 01, 2020 (GLOBE NEWSWIRE) — Peter Rona, President and Chief Executive Officer of Bold Capital Enterprises Ltd. (“Bold”) (TSX-V Bold), a Capital Pool Company, is pleased to announce that its target, Dymedso Inc. (“Dymedso”), closed a private placement of unsecured convertible debentures for the realization of its qualifying transaction (the “Qualifying Transaction”), as per Policy 2.4 of the TSX Venture Exchange (the “Exchange”), for aggregate gross proceeds of approximately C$1,700,000 (the “Offering”).Pursuant to the Offering, Dymedso issued unsecured convertible debentures bearing interest at a rate of 10% (the “Debentures”). The principal amount of the Debenture and the accrued and unpaid interest shall be...

Continue reading

Bold annonce la clôture d’un placement privé d’environ 1 700 000 $CA de débentures convertibles par Dymedso, une société impliquée dans le traitement des maladies pulmonaires et le traitement des problèmes pulmonaires liés à la COVID-19

CE COMMUNIQUÉ NE DOIT PAS ÊTRE DIFFUSÉ, PUBLIÉ OU DISTRIBUÉ, EN TOUT OU EN PARTIE, AUX ÉTATS-UNISMONTRÉAL, 01 oct. 2020 (GLOBE NEWSWIRE) — Peter Rona, président et chef de la direction de Les Entreprises Bold Capital (« Bold ») (TSX-V Bold), une société de capital de démarrage, a le plaisir d’annoncer que sa cible, Dymedso inc. (« Dymedso »), a clôturé un placement privé de débentures convertibles non garanties en vue de la réalisation de son opération admissible (l’« Opération admissible »), conformément à la Politique 2.4 de la Bourse de croissance TSX (la « Bourse »), pour un produit brut total d’environ 1 700 000 $CA (le « Placement »).Dans le cadre du Placement, Dymedso a émis des débentures convertibles non garanties portant intérêt à un taux de 10 % (les « Débentures »). Le montant en principal des Débentures et les intérêts...

Continue reading

Highwoods to Release 2020 Third Quarter Results Tuesday, October 27th

RALEIGH, N.C., Oct. 01, 2020 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE:HIW) will release its 2020 third quarter results on Tuesday, October 27th, after the market closes.A conference call will be held the next day, Wednesday, October 28th, at 11:00 A.M. Eastern time.For US/Canada callers, dial (800) 756-3565. A live, listen-only webcast can be accessed through the Company’s website at www.highwoods.com under the “Investors” section.   A replay of the call will also be available on the Company’s website.About HighwoodsHighwoods Properties, Inc., headquartered in Raleigh, is a publicly-traded (NYSE:HIW) real estate investment trust (“REIT”) and a member of the S&P MidCap 400 Index. The Company is a fully-integrated office REIT that owns, develops, acquires, leases and manages properties primarily in the best business...

Continue reading

LPL Financial Announces Third Quarter 2020 Earnings Release Date and Conference Call

SAN DIEGO, Oct. 01, 2020 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), the parent corporation of leading retail investment advisory firm, independent broker-dealer and registered investment advisor (RIA) custodian LPL Financial LLC, announced it will report third quarter financial results after the market closes on Oct. 29. The Company will host a conference call to discuss its results at 5 p.m. ET the same day. Listeners can call 877-677-9122 (domestic) or 708-290-1401 (international) and use passcode 2390337.The conference call will also be webcast simultaneously on the Investor Relations section of the Company’s website (investor.lpl.com), and a replay will be available on demand until Nov. 19. A telephonic replay will be available beginning approximately two hours after the call and will...

Continue reading

Nanox Announces Live Demonstration of its Nanox.ARC System at Radiology Society of North America (RSNA) 2020

NEVE ILAN, Israel, Oct. 01, 2020 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, is pleased to announce today that it will demonstrate its novel technology (Nanox.SOURCE) and medical imaging system (Nanox.ARC) at RSNA 2020, which is being held November 29-December 5 in Chicago.The demonstration will include a technology section elaborating on Nanox’s first commercial-grade digital x-ray source followed by a live demonstration of the Nanox.ARC in a range of 2D and 3D medical imaging procedures.The demonstration will be led by Mr. Ran Poliakine, Chairman and Chief Executive Officer of Nanox, and will be live streamed globally. It will include a professional radiology Q&A session followed by lectures and presentations of clinical applications of...

Continue reading

Tactile Medical to Release Third Quarter of Fiscal Year 2020 Financial Results on November 2, 2020

MINNEAPOLIS, Oct. 01, 2020 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that third quarter of fiscal year 2020 financial results will be released after the market closes on Monday, November 2.Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on November 2 to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13711024. A live webcast of the call will also be provided on the investor relations section of the Company’s website at investors.tactilemedical.com.For those unable to participate, a replay of...

Continue reading

Xtant Medical Announces Closing of Debt Restructuring

BELGRADE, Mont., Oct. 01, 2020 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has completed its previously announced debt restructuring transaction.The primary purpose of the restructuring was to improve Xtant’s capital structure by reducing its outstanding debt, which the Company expects will facilitate future access to capital markets for investment in its growth initiatives, and regain compliance with the NYSE American’s continued listing standards.“We are pleased to have completed this debt restructuring transaction, which significantly reduced Xtant’s total indebtedness to less than $16 million under our credit facility, lowered our cost of debt to more serviceable levels,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.